UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000016865
Receipt number R000019575
Scientific Title Preliminary study of the effect of tokishakuyakusan on ocular blood flow in the patients with normal tension glaucoma
Date of disclosure of the study information 2015/03/21
Last modified on 2019/04/03 17:47:53

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Preliminary study of the effect of tokishakuyakusan on ocular blood flow in the patients with normal tension glaucoma

Acronym

The effect of tokishakuyakusan on ocular blood flow in the patients with normal tension glaucoma

Scientific Title

Preliminary study of the effect of tokishakuyakusan on ocular blood flow in the patients with normal tension glaucoma

Scientific Title:Acronym

The effect of tokishakuyakusan on ocular blood flow in the patients with normal tension glaucoma

Region

Japan


Condition

Condition

normal tension glaucoma

Classification by specialty

Cardiology Ophthalmology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the change of condition including ocular blood flow in normal tension glaucoma with adding tokishakuyakusan to conventional therapy

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

ocular blood flow

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Traditional Japanese Kampo medicine tokishakuyakusan (TJ-23), 7.5g/day, orally, for 6 months

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

60 years-old >

Gender

Female

Key inclusion criteria

1. systolic blood pressure < 130 mmHg and systolic blood pressure < 85 mmHg
2. intra ocular pressure <= 21 mmHg
3. with no significant abnormality in an examination for slit lamp microscopy and angle
4. with glaucoma-related optic disc shape in funduscopy
5. with glaucoma-related field change by at least two times of reliable visual field tests
6. written informed consent can be obtained from the participant

Key exclusion criteria

1. When there is hypotension, circulatory disease, endocrine disease, a cause including excessive anemia are identified, and the cause is judged if treatment is necessary.
2. pregnant
3. history of allergy to Kampo medicine
4. history of unpleasantness, gastrointestinal disorder by the Kampo medicine

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Shin
Middle name
Last name Takayama

Organization

Tohoku University Graduate School of Medicine

Division name

Comprehensive Education Center for Community Medicine

Zip code

981-8575

Address

2-1, Seiryo-machi, Aoba ward, Sendai 980-8575, Japan

TEL

022-717-8010

Email

takayama@med.tohoku.ac.jp


Public contact

Name of contact person

1st name Shin
Middle name
Last name Takayama

Organization

Tohoku University Graduate School of Medicine

Division name

Comprehensive Education Center for Community Medicine

Zip code

981-8575

Address

2-1, Seiryo-machi, Aoba ward, Sendai 980-8575, Japan

TEL

022-717-8010

Homepage URL


Email

takayama@med.tohoku.ac.jp


Sponsor or person

Institute

Tohoku university

Institute

Department

Personal name



Funding Source

Organization

JSPS
KAKEN

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

MHLW Certified Clinical Research Review Board, Tohoku University

Address

2-1-1, Katahira, Aoba ward, Sendai city

Tel

022-718-0461

Email

office@nrs.hosp.tohoku.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2015 Year 03 Month 21 Day


Related information

URL releasing protocol


Publication of results

Partially published


Result

URL related to results and publications


Number of participants that the trial has enrolled

12

Results


Results date posted


Results Delayed

Delay expected

Results Delay Reason

Writing the manuscript

Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2014 Year 10 Month 16 Day

Date of IRB

2014 Year 10 Month 16 Day

Anticipated trial start date

2015 Year 04 Month 01 Day

Last follow-up date

2019 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2015 Year 03 Month 21 Day

Last modified on

2019 Year 04 Month 03 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000019575


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name